The Supreme Court has rejected an appeal from Johnson & Johnson seeking to undo a damages award against it over allegations that asbestos in its talc powder products caused women to develop cancer. The company must now pay $2.1 billion in damages to 20 women…
The recent unsuccessful attempt by Zimmer Biomet Inc. to undo a $3.55 million verdict regarding its defective M2a Magnum hip implant shows how the company continues to evade responsibility for the pain and suffering inflicted on patients by their flawed and dangerous implant. A federal…
In one of the latest developments following the U.S. Food & Drug Administration’s recall of Zantac products, the Department of Justice is reportedly investigating two of the drug’s primary manufacturers for possible violations of the False Claims Act. After issuing several warnings, the FDA in…
An avalanche of sexual abuse cases has forced the Boy Scouts of America to file for bankruptcy. The court overseeing that bankruptcy has set November 16, 2020, as the deadline for survivors of sexual abuse to file claims. It is urgent for victims with legitimate…
Attorneys for both the Boy Scouts of America and survivors of sexual abuse have reached a compromise in setting a bar date for claims to be submitted to the bankruptcy court. Attorneys for survivors of Boy Scout sexual abuse had argued for a December 31…
According to recent studies the widely used bladder drug Elmiron may cause eye damage. Recent reports suggest that the drug — known as pentosan polysulfate sodium and used by hundreds of thousands of people for decades — may be toxic to the retina, the light-sensing…
The U.S. Food and Drug Administration in February requested that weight loss drug Belviq be pulled from the market due to cancer concerns. Now, a New York woman named Barbara Zottola has filed a class action lawsuit against the drug’s manufacturer, claiming it knew about…
Following the FDA’s recent recall of Zantac and other ranitidine medications, a major pharmaceutical company is voluntarily taking a related prescription drug, Nizatidine, off the market. On April 1, 2020, the FDA confirmed that ranitidine products could produce high levels of a possible cancer-causing substance…
The U.S. Food and Drug Administration is advising consumers who take Zantac, or generic forms of ranitidine, to stop taking the drug following research linking it to a cancer-causing agent. The advisory comes as part of the FDA’s newly issued request for the immediate removal…
Our firm is fully electronic and all staff are working remotely from home. We are processing settlements and moving our litigation cases forward. Judges in state and federal courts are holding hearings by telephone conference to keep cases moving. We are working with court reporters…
